Patent details

EP2346848 Title: QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS

Basic Information

Publication number:
EP2346848
PCT Application Number:
PCT/EP/2009/064604
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097444145
PCT Publication Number:
WO/2010/054968
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS
French Title of Invention:
DÉRIVÉS DE QUINAZOLINE COMME ANTAGONISTES DES RÉCEPTEURS NK3
German Title of Invention:
CHINAZOLINDERIVATE ALS ANTAGONISTEN DES NK3-REZEPTORS
SPC Number:

Dates

Filing date:
04/11/2009
Grant date:
27/02/2013
EP Publication Date:
27/02/2013
PCT Publication Date:
20/05/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/07/2011
EP B1 Publication Date:
27/02/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/11/2013
Expiration date:
04/11/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/11/2009
 
 

Name:
F.Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:
VIFIAN Walter
Address:
Switzerland (CH)

2

Name:
RATNI Hasane
Address:
France (FR)

3

Name:
KNUST Henner
Address:
Germany (DE)

4

Name:
RIEMER Claus
Address:
Germany (DE)

5

Name:
LIMBERG Anja
Address:
Switzerland (CH)

6

Name:
NETTEKOVEN Matthias
Address:
Germany (DE)

Priority

Priority Number:
08169162
Priority Date:
14/11/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 401/04;
Filing date Document type Number of pages